A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be available.
A 2025 clinical trial reports the first-ever strength improvement in ALS patients using intranasally delivered MSC exosomes — zero adverse events across 32 treatments.
MSC-derived exosomes are reshaping regenerative medicine — learn how these nano-sized vesicles deliver therapy without the risks of whole-cell transplantation.
Thailand’s active lifestyle—temple stairs, muay thai, beach volleyball—takes a toll on knees. Knee replacement surgery leaves 30% of patients dissatisfied. Our Bangkok clinic offers a better solution: precision-guided MSC and exosome therapy that regenerates cartilage naturally.
The regenerative medicine world is buzzing about exosomes—tiny vesicles that do the heavy lifting of stem cells without the cells themselves. Our Bangkok clinic pioneered exosome therapy in Thailand, offering a safer, more targeted alternative to traditional stem cell treatments.
Russian 
English 
Chinese 
French